未知の原発部位の癌である
Nicholas Pavlidis1, George Pentheroudakis
1Department of Medical Oncology, School of Medicine, University of Ioannina, Ioannina, Greece. npavlid@uoi.gr
Lancet (London, England)
|March 15, 2012
まとめ
未知の原発部位 (CUP) がんは,攻撃的ながんである. 主要部位を特定することは,治療に役立ちますが,好ましいおよび不利な予後サブセットの明確な結果が得られます.
科学分野:
- 腫瘍学 腫瘍学
- がん研究 がん研究
背景:
- 未知の原発部位 (CUP) がんは,上皮がんの3〜5%を占めています.
- CUPは,攻撃的な行動と早期転移が特徴です.
研究 の 目的:
- CUPの診断方法を見直す.
- 異なるCUP予後サブセットの治療戦略とアウトカムについて議論する.
主な方法:
- ヒストパト学的検査,免疫ヒスト化学,放射線学的評価のレビュー.
- 遺伝子プロファイリングマイクロアレイ診断の議論.
- 予後サブセットに基づく治療反応と生存率の分析.
主要な成果:
- 転移性アデノカルシノーマは,最も一般的なCUPサブタイプ (80%).
- 好ましい (20%) と不利な (80%) 予後サブセットが存在します.
- ロコ地域性またはプラチナベースの化学療法で治療された好ましいサブセットは,既知のプライマリーと同様の結果を示しています.
- 経験的化学療法で治療された不利なサブセットは,弱い反応と生存率を持っています.
結論:
- 正確な診断とサブセットは,CUP管理に不可欠です.
- 好ましいサブセットの標的治療は,結果を改善します.
- 不利なCUPサブセットの治療を最適化するためにさらなる研究が必要である.
関連する概念動画
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

